Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Regul Toxicol Pharmacol ; 60(3): 308-17, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21545823

RESUMEN

Within the framework of REACH, an assessment regarding local dermal effects and skin sensitisation should be performed for substances. Quantitative hazard information for these effects is often not available. Furthermore, it is difficult to relate the way in which animals are exposed in dermal toxicity studies directly to dermal exposure in practice. In the absence of quantitative information, a qualitative assessment for dermal effects is the most reasonable option. The qualitative approach as proposed in the REACH guidance recommends only general risk management measures (RMM) for three categories with a low, moderate and high identified hazard, without specifying which RMM are needed for a specific exposure scenario. We propose to differentiate frequency of exposure based on differences in activities and to compare measured and estimated local skin exposure levels with rules of thumb for evaluation of control of risks per hazard category. For workers, specific RMM regimes are assigned to each combination of hazard category and process category (PROC). For consumers, a strategy in which RMM are arranged from product-integrated measures to the use of personal protective equipment (PPE) is presented. Our approach may be transferred into automated assessment tools like Chesar and CEFIC GES.


Asunto(s)
Sustancias Peligrosas/toxicidad , Exposición Profesional/efectos adversos , Medición de Riesgo/legislación & jurisprudencia , Piel/efectos de los fármacos , Animales , Unión Europea , Humanos , Inmunización , Medición de Riesgo/métodos , Gestión de Riesgos , Absorción Cutánea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA